Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy

By                      

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 723-730

Spandidos Publications

Access to resources Recommend Favorite

Role of Non-Taxane-Containing Chemotherapy in Advanced Non-Small Cell Lung Cancer

By Bergqvist Michael  

American Journal of Cancer, Vol. 5, Iss. 4, 2006-01 ,pp. : 223-244

Adis International

Access to resources Recommend Favorite

Similar survival benefits of a good response and stable disease to platinum-based chemotherapy in non-small cell lung cancer

By            

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1135-1140

Spandidos Publications

Access to resources Recommend Favorite

Role of BCL2-associated athanogene in resistance to platinum-based chemotherapy in non-small-cell lung cancer

By            

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 984-990

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

By Mori Kiyoshi   Kamiyama Yukari   Kondo Tetsuro   Kano Yasuhiko   Kodama Tetsuro  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite